Office of Prescription Drug Promotion (OPDP)

government

Last mentioned: Mar 9, 2026

Stories mentioning Office of Prescription Drug Promotion (OPDP) 2

regulation Neutral

The Battle Over the Airwaves: Reevaluating Direct-to-Consumer Drug Advertising

A renewed public debate over Direct-to-Consumer Advertising (DTCA) is challenging the pharmaceutical industry's marketing status quo in the United States. As healthcare costs escalate, regulators and lawmakers are weighing the educational benefits of patient outreach against the risks of over-prescription and inflated drug prices.

3 sources
regulation Neutral

Regulatory Crossroads: The Future of Direct-to-Consumer Pharma Advertising

The debate over Direct-to-Consumer (DTC) pharmaceutical advertising is intensifying as U.S. regulators face mounting pressure to align with global standards. With the U.S. remaining one of only two nations allowing the practice, new legal and ethical challenges are questioning the impact of multi-billion dollar marketing budgets on drug pricing and patient safety.

3 sources